Authors Hannah Thurgur,  Anne Katrin Schlag,  Elizabeth Iveson,  Adele Hosseini,  Michael Lynskey,  David J. Nutt Published August 31, 2023 Abstract  Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can result in…

We are delighted to share the news that the results from the Long COVID trial have been published by the British Journal of Clinical Pharmacology. Access Publication Long COVID, a…

Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background Cannabis-based medicinal products (CBMPs) are increasingly being used to treat post-traumatic stress disorder…

Authors Alkyoni Athanasiou-Fragkouli, Michael Lynskey, Anne Schlag and David Nutt Published June 5, 2024 Background Chronic pain is one of the most common conditions for which people seek treatment with…

Authors Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou‑Fragkouli, Anne K. Schlag and David J. Nutt Published June 17, 2024 Abstract Background Previous research has suggested that the use of cannabis-based…

Authors Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou‑Fragkouli, Anne K. Schlag and David J. Nutt Published July 24, 2024 Abstract Objective To document the prevalence and correlates of suicidal ideation…

Since its inception in 2019, T21 has strived to create the largest body of evidence for the safety and efficacy of medical cannabis, providing patients with access to affordable treatment…

Authors Hallie Heeg, Ana Morari, Michael Lynskey and John JD Turner Published September 25, 2024 Background In the UK, there are over 40,000 specialist clinicians who are eligible to prescribe…

Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study. The research…